Neutrophil Extracellular Traps (NETs) drives Blood-Brain Barrier (BBB) leakage, Hippocampal neuronal damage and Cognitive dysfunction: A Therapeutic approach by DNase1
This study demonstrates that Neutrophil Extracellular Traps (NETs) drive blood-brain barrier leakage, hippocampal neuronal damage, and cognitive dysfunction in an LPS-induced mouse model, and that therapeutic degradation of NETs using DNase1 effectively restores barrier integrity, mitigates neuroinflammation, and improves cognitive function.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
As people live longer, the risk of losing their sharpness of mind grows, becoming a profound challenge for families and societies worldwide. Scientists have long known that the brain is protected by a specialized border, a tight seal between the blood and the brain tissue that keeps harmful substances out while letting in what is needed. This barrier is built from cells held together by strong protein links, acting like a high-security gate. When this gate begins to leak, even slightly, it can set off a chain reaction that damages brain cells and leads to memory loss. Recent research has turned its attention to the immune system's first responders, white blood cells called neutrophils. When these cells fight infection, they sometimes release a sticky, web-like trap made of DNA and enzymes to catch invaders. While useful in the body, these traps can become destructive if they form inside the brain, potentially tearing down the protective gate and harming the very cells responsible for our thoughts and memories.
In a new study, researchers at GITAM University in India investigated exactly how these immune traps might be driving cognitive decline and whether they could be stopped. The team used a mouse model to simulate a state of severe inflammation, a condition known to trigger the release of these DNA webs. They focused on a specific part of the brain called the hippocampus, which is essential for forming new memories, and the dentate gyrus, a region within it that is often the first to show signs of damage in aging and disease. The researchers wanted to see if these immune traps were actually entering the brain, breaking down the protective barrier, and causing the animals to lose their ability to learn and move with coordination. To test this, they introduced a substance called DNase1, an enzyme that acts like molecular scissors, specifically designed to cut up the DNA in these traps and clear them away.
The results showed a clear and damaging pattern in the mice that received the inflammation trigger. Inside the brains of these animals, the researchers found a significant buildup of the immune traps, visible as thread-like structures rich in a specific enzyme called neutrophil elastase. These structures were not just floating nearby; they had infiltrated the hippocampus and the choroid plexus, a region that helps produce the fluid surrounding the brain. This invasion coincided with a breakdown of the protective gate. The protein links that hold the brain's blood vessels together, known as claudin-5, dropped in number, and the barrier became leaky enough to let a blue dye, injected into the bloodstream, seep into the brain tissue. This physical damage translated directly into behavior. The mice struggled to stay balanced on a rotating rod, showed poor memory in tests where they had to recognize new objects, and failed to remember the layout of a maze. Their brains also showed signs of severe stress, with damaged mitochondria—the tiny power plants inside cells—and a buildup of harmful oxidative byproducts that can corrode cell membranes.
However, when the researchers treated the mice with DNase1, the outcome changed dramatically. The enzyme successfully degraded the immune traps, clearing the brain of the sticky DNA webs and the associated enzymes. With the traps removed, the protective barrier showed signs of healing; the protein links returned to normal levels, and the blue dye stayed out of the brain tissue. The mice treated with the enzyme performed better on the behavioral tests, showing improved balance and an enhanced ability to recognize new things, although the improvement in balance did not reach statistical significance. Inside their brains, the signs of oxidative stress and mitochondrial damage were significantly reduced, and the levels of inflammatory signals that usually scream for help from the immune system dropped back down. The tissue looked healthier, with fewer dead or shrunken cells and less evidence of the cellular chaos seen in the untreated group.
The study also looked closely at what was not happening to ensure the findings were precise. While the researchers expected to see a drop in one specific antioxidant enzyme called superoxide dismutase, they found no significant difference in its activity between the groups. This ruled out the idea that the damage was being driven by a lack of this particular defense, pointing instead to a different mechanism involving hydrogen peroxide and lipid peroxidation, which were indeed elevated. The team confirmed that the damage was driven by the immune traps themselves, as removing them with DNase1 reversed the effects, revealing informative biological patterns despite some variance in statistical significance. The researchers noted that this approach uses an enzyme already approved for human use in treating a different lung condition, suggesting that the path to testing this in people might be shorter than for entirely new drugs. By showing that clearing these immune traps can repair the brain's protective wall and restore cognitive function, the study offers a tangible new direction for understanding and potentially treating the early stages of memory loss and brain aging.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.